ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
Expediting Reimbursement and Access for Novel Drug Indications in Europe: A Case Study on Glucagon-Like Peptide 1 (GLP-1) Agonists
Nov 19, 2024, 10:30 AM
«
1581
1582
1583
1584
1585
1586
1587
(current)
1588
1589
1590
»